Critical review of non-statin treatments for dyslipoproteinemia.

about

Pharmacogenomics, lipid disorders, and treatment options.Lomitapide for use in patients with homozygous familial hypercholesterolemia: a narrative review.

P2860

Q38203774-14AFBD8D-F99E-4615-A3D4-7CEB3F280496 Q38760884-D86A5515-D945-4915-8715-929D7C8F2257

P2860

Critical review of non-statin treatments for dyslipoproteinemia.

Item

http://www.wikidata.org/entity/Q38186099

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Critical review of non-statin treatments for dyslipoproteinemia.

@en

type

Item

label

Critical review of non-statin treatments for dyslipoproteinemia.

@en

prefLabel

Critical review of non-statin treatments for dyslipoproteinemia.

@en

P1476

Critical review of non-statin treatments for dyslipoproteinemia

@en

P2093

Dick C Chan

http://www.w3.org/2001/XMLSchema#string

Gerald F Watts

http://www.w3.org/2001/XMLSchema#string

Jing Pang

http://www.w3.org/2001/XMLSchema#string

P2860

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

Lipoprotein(a) as a cardiovascular risk factor: current status

Association of an intensive lifestyle intervention with remission of type 2 diabetes.

Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass

Effect of aspirin on lipoprotein(a) in patients with ischemic stroke

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial

Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

Simvastatin with or without ezetimibe in familial hypercholesterolemia

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

P304

359-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2014.888312

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jing Pang

Dick Chan

G F Watts

P577

2014-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24506448

http://www.w3.org/2001/XMLSchema#string

Critical review of non-statin treatments for dyslipoproteinemia.

about

P2860

P2860

Critical review of non-statin treatments for dyslipoproteinemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698